Summary
Immunotherapies targeting immune regulators are revolutionizing cancer treatment, most prominently in melanoma, but only for a subset of patients. While it is known that the immune tumor microenvironment (iTME) plays a vital role in this process, there is limited understanding...
More information & hyperlinks
Web resources: | https://www.weizmann.ac.il/mcb/Keren/home |